• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨转换标志物能否反映甲状腺功能障碍患者治疗期间骨微结构的变化?

Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?

作者信息

Vinther C J, Poulsen L H, Nicolaisen P, Obling M L, Brix T H, Hermann A P, Hegedüs L, Jørgensen N R, Hansen S, Bonnema S J

机构信息

Department of Endocrinology, Odense University Hospital, Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

出版信息

J Endocrinol Invest. 2023 Feb;46(2):345-358. doi: 10.1007/s40618-022-01907-2. Epub 2022 Sep 5.

DOI:10.1007/s40618-022-01907-2
PMID:36064878
Abstract

PURPOSE

This study aimed to compare changes in the bone turnover markers (BTMs)-C-terminal telopeptide of type I collagen (CTX-I) and procollagen I N-terminal peptide (PINP)-with changes in the bone microarchitecture, assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT), during treatment of patients with thyroid dysfunction.

METHODS

In women with newly diagnosed hypo- or hyperthyroidism, HR-pQCT variables, obtained from the tibia and the radius, were compared with BTMs. Data were collected at diagnosis and after at least 12 months of euthyroidism.

RESULTS

73 women completed the study (hypothyroidism, n = 27; hyperthyroidism, n = 46). Among hyperthyroid patients, correlations were found between changes in BTMs and HR-pQCT variables, primarily for cortical variables in the tibia, i.e. cortical thickness (CTX-I, p < 0.001; PINP, p < 0.001), and volumetric bone mass density (vBMD) (CTX-I, p < 0.001; PINP, p < 0.001). Moreover, correlations between BTMs and estimated bone strength were found. In the hypothyroid subgroup, no significant findings existed after adjustment. Following treatment, less decrease in tibial vBMD was seen among patients with increasing CTX-I compared to those with a decreasing CTX-I level (p = 0.009). Opposite findings applied to PINP, as patients with decreasing PINP showed an increase in tibial vBMD, in contrast to a decline in this parameter among patients with increasing PINP (p < 0.001).

CONCLUSION

Changes in CTX-I and PINP correlated with HR-pQCT variables during the treatment of women with thyroid dysfunction. To some extent, these BTMs reflected the restoration of bone microarchitecture. CTX-I seems to be the most sensitive BTM in treatment-naïve thyroid diseases, while PINP is more useful for monitoring during treatment.

TRIAL REGISTRATION NUMBER

NCT02005250. Date: December 9, 2013.

摘要

目的

本研究旨在比较骨转换标志物(BTMs)——I型胶原C末端肽(CTX-I)和I型前胶原N末端肽(PINP)的变化与通过高分辨率外周定量计算机断层扫描(HR-pQCT)评估的骨微结构变化,这些变化发生在甲状腺功能障碍患者的治疗过程中。

方法

在新诊断为甲状腺功能减退或亢进的女性中,将从胫骨和桡骨获得的HR-pQCT变量与BTMs进行比较。在诊断时以及甲状腺功能正常至少12个月后收集数据。

结果

73名女性完成了研究(甲状腺功能减退,n = 27;甲状腺功能亢进,n = 46)。在甲状腺功能亢进患者中,发现BTMs变化与HR-pQCT变量之间存在相关性,主要是胫骨的皮质变量,即皮质厚度(CTX-I,p < 0.001;PINP,p < 0.001)和骨体积密度(vBMD)(CTX-I,p < 0.001;PINP,p < 0.001)。此外,还发现了BTMs与估计骨强度之间的相关性。在甲状腺功能减退亚组中,调整后未发现显著结果。治疗后,与CTX-I水平下降的患者相比,CTX-I升高的患者胫骨vBMD下降较少(p = 0.009)。PINP则相反,PINP下降的患者胫骨vBMD增加,而PINP升高的患者该参数下降(p < 0.001)。

结论

在甲状腺功能障碍女性的治疗过程中,CTX-I和PINP的变化与HR-pQCT变量相关。在一定程度上,这些BTMs反映了骨微结构的恢复。CTX-I似乎是初治甲状腺疾病中最敏感的BTM,而PINP在治疗期间监测更有用。

试验注册号

NCT02005250。日期:2013年12月9日。

相似文献

1
Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?骨转换标志物能否反映甲状腺功能障碍患者治疗期间骨微结构的变化?
J Endocrinol Invest. 2023 Feb;46(2):345-358. doi: 10.1007/s40618-022-01907-2. Epub 2022 Sep 5.
2
Association between changes in serum bone metabolism markers and bone microarchitecture changes during basic combat training - The ARMI study.血清骨代谢标志物变化与基础战斗训练期间骨微观结构变化的相关性研究——ARMI 研究。
Bone. 2024 Dec;189:117241. doi: 10.1016/j.bone.2024.117241. Epub 2024 Aug 23.
3
Reference intervals for serum concentrations of three bone turnover markers for men and women.男性和女性三种骨转换标志物血清浓度参考区间。
Bone. 2013 Dec;57(2):399-404. doi: 10.1016/j.bone.2013.09.010. Epub 2013 Sep 27.
4
Rapid bone microarchitecture decline in older men with high bone turnover-the prospective STRAMBO study.老年男性骨转换率高者骨微结构快速下降——前瞻性 STRAMBO 研究。
J Bone Miner Res. 2024 Mar 4;39(1):17-29. doi: 10.1093/jbmr/zjad015.
5
Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.骨转换标志物与老年男性和女性的骨体积密度、大小及强度相关吗?AGES-雷克雅未克研究。
Osteoporos Int. 2016 May;27(5):1765-76. doi: 10.1007/s00198-015-3442-1. Epub 2015 Dec 2.
6
Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.母亲与女儿骨转换率的家族相似性——MODAM研究
Osteoporos Int. 2015 Mar;26(3):921-30. doi: 10.1007/s00198-014-2974-0. Epub 2014 Dec 19.
7
Consequences of Hyperthyroidism and Its Treatment for Bone Microarchitecture Assessed by High-Resolution Peripheral Quantitative Computed Tomography.高分辨率外周定量计算机断层扫描评估甲状腺功能亢进及其治疗对骨微观结构的影响。
Thyroid. 2021 Feb;31(2):208-216. doi: 10.1089/thy.2020.0084. Epub 2020 Nov 12.
8
Age-related trends and reference intervals of cross-linked C-telopeptide of type I collagen and procollagen type I N-propeptide from a reference population of Sri Lankan adult women.来自斯里兰卡成年女性参考人群的Ⅰ型胶原交联 C 端肽和前胶原Ⅰ N 端肽的年龄相关趋势和参考区间。
Arch Osteoporos. 2021 Nov 2;16(1):164. doi: 10.1007/s11657-021-01022-4.
9
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.CTX-I 和 PINP 作为骨转换标志物的应用:国家骨健康联盟建议规范样本处理和患者准备,以减少分析前的变异性。
Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19.
10
Changes in bone mass and bone turnover following tibial shaft fracture.胫骨干骨折后骨量和骨转换的变化
Osteoporos Int. 2006;17(3):364-72. doi: 10.1007/s00198-005-2025-y. Epub 2005 Dec 15.

引用本文的文献

1
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).骨转换标志物在骨质疏松症诊断和管理中的作用更新:来自欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)、国际骨质疏松症基金会(IOF)以及国际临床化学和检验医学联合会(IFCC)的共识文件。
Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28.
2
Changes in bone density and microarchitecture following treatment of Graves' disease and the effects of vitamin D supplementation. A randomized clinical trial.治疗格雷夫斯病后骨密度和微结构的变化以及维生素 D 补充的影响。一项随机临床试验。
Osteoporos Int. 2024 Dec;35(12):2153-2164. doi: 10.1007/s00198-024-07241-y. Epub 2024 Sep 12.